Who Paid My Doc
A Randomized, Double-Blind, Placebo-Controlled Study to Investigate TH
Research payments
$496,222
Through program year 2025, $496,222 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled Study to Investigate TH, across 62 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $82,783 | 16 |
| 2024 | Research | $188,132 | 27 |
| 2023 | Research | $174,420 | 16 |
| 2022 | Research | $50,887 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Basil Kahwash Columbus, OH Named on 12 payments
- Frances Lee Atlanta, GA Named on 8 payments
- Mili Shum Murray, UT Named on 8 payments
- Kelli Williams Charleston, SC Named on 6 payments
- Thanai Pongdee Rochester, MN Named on 4 payments
- Jason Karp Manhasset, NY Named on 3 payments
- Marc Rothenberg Cincinnati, OH Named on 2 payments
- Howard Terebelo Ann Arbor, MI Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.